FDA Adverse Event
Injury
Summary report: N
BLT Ø3.3MM NC, SLACTIVE® 14MM, TIZR, NTP
MDR report key: 13119867
·
Received December 30, 2021
Report
- Report Number
- 0001222315-2021-23021
- Event Type
- Injury
- Date Received
- December 30, 2021
- Date of Event
- November 8, 2021
- Report Date
- December 30, 2021
- Manufacturer
- INSTITUT STRAUMANN AG
- Product Code
- DZE
- UDI-DI
- 07630031706645
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- AR, US
- Reporter Occupation
- DENTIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED 2021-07-15 IN ADA 11. ON 2021-11-08, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2018030 | BLT Ø3.3MM NC, SLACTIVE® 14MM, TIZR, NTP | ENDOSSEOUS DENTAL IMPLANT | DZE | INSTITUT STRAUMANN AG | SLActive Roxolid BL | FNL04 | 07630031706645 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |